Literature DB >> 12822734

The colon as a possible target for orally administered peptide and protein drugs.

Susan Haupt1, Abraham Rubinstein.   

Abstract

Oral administration offers a potential portal to the superficial layers of the gastrointestinal (GI) tract (local delivery) and to the blood and lymphatics (systemic delivery). The harsh hydrolytic environment of the GI tract and the epithelial barriers to absorption, however, pose major challenges to the success of this mode of drug delivery for peptide and protein drugs. One approach to minimizing enzymatic degradation in the GI tract is to target drugs to the apparently less proteolytically active colon. In this review, the evidence supporting the colon as an attractive site for peptide and protein drug delivery will be discussed. The discussion will be confined to specific examples of delivery systems bearing both peptides and proteins that have been tested in the colonic context.

Mesh:

Substances:

Year:  2002        PMID: 12822734     DOI: 10.1615/critrevtherdrugcarriersyst.v19.i6.10

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  8 in total

1.  A novel injection-molded capsular device for oral pulsatile delivery based on swellable/erodible polymers.

Authors:  Andrea Gazzaniga; Matteo Cerea; Alberto Cozzi; Anastasia Foppoli; Alessandra Maroni; Lucia Zema
Journal:  AAPS PharmSciTech       Date:  2011-01-26       Impact factor: 3.246

2.  Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice.

Authors:  Tao Wu; Wei-Liang Zheng; Shi-Zheng Zhang; Ji-Hong Sun; Hong Yuan
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

Review 3.  Therapeutic applications of hydrogels in oral drug delivery.

Authors:  Lindsey A Sharpe; Adam M Daily; Sarena D Horava; Nicholas A Peppas
Journal:  Expert Opin Drug Deliv       Date:  2014-06       Impact factor: 6.648

4.  Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice.

Authors:  Song-Qi Gao; Zheng-Rong Lu; Pavla Kopecková; Jindrich Kopecek
Journal:  J Control Release       Date:  2006-10-27       Impact factor: 9.776

5.  Pharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA copolymer-9-AC conjugate in rats.

Authors:  Song-Qi Gao; Yongen Sun; Pavla Kopecková; C Matthew Peterson; Jindrich Kopecek
Journal:  Pharm Res       Date:  2007-10-11       Impact factor: 4.200

Review 6.  Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.

Authors:  Ashaben Patel; Mitesh Patel; Xiaoyan Yang; Ashim K Mitra
Journal:  Protein Pept Lett       Date:  2014       Impact factor: 1.890

Review 7.  Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review.

Authors:  Maryam Ghanbari-Movahed; Tea Kaceli; Arijit Mondal; Mohammad Hosein Farzaei; Anupam Bishayee
Journal:  Biomedicines       Date:  2021-04-27

8.  Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil.

Authors:  M Biswaranjan Subudhi; Ankit Jain; Ashish Jain; Pooja Hurkat; Satish Shilpi; Arvind Gulbake; Sanjay K Jain
Journal:  Materials (Basel)       Date:  2015-02-27       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.